Bio-Techne Accelerates Growth

Bio-Techne had enjoyed robust, double digit growth for many years but following the financial crisis its annual growth had slowed to the single digit range. The Bio-Techne board wanted to accelerate top line growth while retaining the already impressive profitability of the business.

A new Catalyze case study describes how Strategic Portfolio Management has helped Bio-Techne begin to realize improved growth consistent with their Strategic Plan.

Bio-Techne Accelerates GrowthCase Study: Bio-Techne Accelerates Growth

Leave a Reply

Your email address will not be published. Required fields are marked *

Real person test: *